World J Mens Health.  2015 Apr;33(1):8-13. 10.5534/wjmh.2015.33.1.8.

Semen Analysis in Cancer Patients Referred for Sperm Cryopreservation before Chemotherapy over a 15-Year Period in Korea

Affiliations
  • 1Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea. joon501@naver.com

Abstract

PURPOSE
This study evaluated the demographics and semen parameters of males with cancer who banked their sperm prior to chemotherapy.
MATERIALS AND METHODS
This is a retrospective study of 66 cases referred for sperm banking prior to initiation of chemotherapy over a 15-year period (1999~2014). Patients who had previously received cancer treatment including chemotherapy or radiotherapy were not included in this study.
RESULTS
We studied a total of 66 cancer patients referred for cryopreservation of sperm prior to chemotherapy. The mean age of the patients at the time of banking was 32.0+/-7.9 years (range, 19~58 years). The types of cancer were testicular cancer (31 cases, 47.0%), non-Hodgkin's disease (10 cases, 15.1%), Hodgkin's disease (5 cases, 7.6%), leukemia (8 cases, 12.1%), gastrointestinal malignancy (5 cases, 7.6%), and musculoskeletal malignancy (5 cases, 7.6%). There were significant differences in sperm concentration and viability among the various types of cancer, but no significant difference in semen volume or sperm motility and morphology.
CONCLUSIONS
In this study we found that sperm quality could decrease even before chemotherapy. Because chemotherapy can also negatively affect spermatogenesis, sperm cryopreservation prior to treatment should be strongly recommended for cancer patients of reproductive age.

Keyword

Cryopreservation; Drug therapy; Infertility, male; Semen

MeSH Terms

Cryopreservation*
Demography
Drug Therapy*
Hodgkin Disease
Humans
Infertility, Male
Korea
Leukemia
Male
Radiotherapy
Retrospective Studies
Semen
Semen Analysis*
Sperm Banks
Sperm Motility
Spermatogenesis
Spermatozoa*
Testicular Neoplasms

Cited by  1 articles

Long-Term Experience of Sperm Cryopreservation in Cancer Patients in a Single Fertility Center
Seung-Hun Song, Dae Keun Kim, Su Ye Sung, Young Sun Her, Ok-Hee Lee, Myoung Hwa Choi, Hae Kyung Kim, Sang Woo Lyu, Dong Suk Kim
World J Mens Health. 2019;37(2):219-225.    doi: 10.5534/wjmh.180061.


Reference

1. Tschudin S, Bitzer J. Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Hum Reprod Update. 2009; 15:587–597.
Article
2. Glaser AW, Phelan L, Crawshaw M, Jagdev S, Hale J. Fertility preservation in adolescent males with cancer in the United Kingdom: a survey of practice. Arch Dis Child. 2004; 89:736–737.
Article
3. Puscheck E, Philip PA, Jeyendran RS. Male fertility preservation and cancer treatment. Cancer Treat Rev. 2004; 30:173–180.
Article
4. Rofeim O, Gilbert BR. Normal semen parameters in cancer patients presenting for cryopreservation before gonadotoxic therapy. Fertil Steril. 2004; 82:505–506.
Article
5. Sabanegh ES Jr, Ragheb AM. Male fertility after cancer. Urology. 2009; 73:225–231.
Article
6. Lass A, Abusheikha N, Akagbosu F, Brinsden P. Cancer patients should be offered semen cryopreservation. BMJ. 1999; 318:1556.
Article
7. Bahadur G, Farhi J, Ling KL, Techatraisak K, Ashraf A, Oyede AW, et al. Pregnancy and miscarriage rates in 3978 donor insemination cycles: effect of age, parity and partner's infertility status on pregnancy outcome. Hum Fertil (Camb). 2000; 3:207–201.
Article
8. World Health Organization. Laboratory manual of the WHO for the examination of human semen and sperm-cervical mucus interaction. Ann Ist Super Sanita. 2001; 37:I–XII.
9. Spitz S. The histological effects of nitrogen mustards on human tumors and tissues. Cancer. 1948; 1:383–398.
Article
10. Gandini L, Sgrò P, Lombardo F, Paoli D, Culasso F, Toselli L, et al. Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients. Hum Reprod. 2006; 21:2882–2889.
Article
11. Pont J, Albrecht W. Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril. 1997; 68:1–5.
Article
12. Kenney LB, Laufer MR, Grant FD, Grier H, Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001; 91:613–621.
Article
13. Keene DJ, Sajjad Y, Makin G, Cervellione RM. Sperm banking in the United Kingdom is feasible in patients 13 years old or older with cancer. J Urol. 2012; 188:594–597.
Article
14. Amirjannati N, Sadeghi M, Hosseini Jadda SH, Ranjbar F, Kamali K, Akhondi MA. Evaluation of semen quality in patients with malignancies referred for sperm banking before cancer treatment. Andrologia. 2011; 43:317–320.
Article
15. Bizet P, Saias-Magnan J, Jouve E, Grillo JM, Karsenty G, Metzler-Guillemain C, et al. Sperm cryopreservation before cancer treatment: a 15-year monocentric experience. Reprod Biomed Online. 2012; 24:321–330.
Article
16. Chung JP, Haines CJ, Kong GW. Sperm cryopreservation for Chinese male cancer patients: a 17-year retrospective analysis in an assisted reproductive unit in Hong Kong. Hong Kong Med J. 2013; 19:525–530.
Article
17. Hagenäs I, Jørgensen N, Rechnitzer C, Sommer P, Holm M, Schmiegelow K, et al. Clinical and biochemical correlates of successful semen collection for cryopreservation from 12-18-year-old patients: a single-center study of 86 adolescents. Hum Reprod. 2010; 25:2031–2038.
18. Ping P, Zhu WB, Zhang XZ, Yao KS, Xu P, Huang YR, et al. Sperm banking for male reproductive preservation: a 6-year retrospective multi-centre study in China. Asian J Androl. 2010; 12:356–362.
Article
19. Said TM, Tellez S, Evenson DP, Del Valle AP. Assessment of sperm quality, DNA integrity and cryopreservation protocols in men diagnosed with testicular and systemic malignancies. Andrologia. 2009; 41:377–382.
Article
20. Klosky JL, Randolph ME, Navid F, Gamble HL, Spunt SL, Metzger ML, et al. Sperm cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol. 2009; 26:252–260.
Article
21. Bonetti TC, Pasqualotto FF, Queiroz P, Iaconelli A Jr, Borges E Jr. Sperm banking for male cancer patients: social and semen profiles. Int Braz J Urol. 2009; 35:190–197.
Article
22. Williams DH 4th, Karpman E, Sander JC, Spiess PE, Pisters LL, Lipshultz LI. Pretreatment semen parameters in men with cancer. J Urol. 2009; 181:736–740.
Article
23. Crawshaw MA, Glaser AW, Hale JP, Sloper P. Young males' experiences of sperm banking following a cancer diagnosis: a qualitative study. Hum Fertil (Camb). 2008; 11:238–234.
24. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Oncologists' attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol. 2002; 20:1890–1897.
Article
25. Hobbie WL, Ogle SK, Ginsberg JP. Fertility concerns for young males undergoing cancer therapy. Semin Oncol Nurs. 2009; 25:245–250.
Article
26. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006; 24:2917–2931.
Article
27. Heath JA, Stern CJ. Fertility preservation in children newly diagnosed with cancer: existing standards of practice in Australia and New Zealand. Med J Aust. 2006; 185:538–541.
Article
28. Neal MS, Nagel K, Duckworth J, Bissessar H, Fischer MA, Portwine C, et al. Effectiveness of sperm banking in adolescents and young adults with cancer: a regional experience. Cancer. 2007; 110:1125–1129.
29. Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol. 2002; 20:1880–1889.
Article
Full Text Links
  • WJMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr